TREATMENT PATTERNS OF METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC) IN US COMMERCIAL PLANS

被引：0
|
作者：
Jiang, S. [1 ]
Hill, K. [2 ]
Varghese, D. [1 ]
Waldeck, R. [2 ]
Botteman, M. [1 ]
机构：
[1] Pharmerit Int, Bethesda, MD USA
[2] Celldex Therapeut, Hampton, NJ USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN221
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [21] A Phase II randomized trial of pembrolizumab with carboplatin and gemcitabine for treatment of patients with metastatic triple-negative breast cancer (mTNBC)
    Obeid, E.
    Miller, K. D.
    Sparano, J. A.
    Blackwell, K.
    Goldstein, L. J.
    CANCER RESEARCH, 2017, 77
  • [22] Results of a phase II study of capecitabine-based doublets in the treatment of metastatic triple-negative breast cancer (mTNBC)
    Fan, Ying
    Xu, Binghe
    Liao, Yuqian
    Ma, Fei
    Yuan, Peng
    Wang, Jiayu
    Zhang, Pin
    Li, Qing
    Xuan, Lixue
    Luo, Yang
    Ding, Xiaoyan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Treatment patterns and costs of metastatic triple negative breast cancer (mTNBC) in US women: A retrospective cohort study of first-line chemotherapy
    Tabah, Ashley
    Copher, Ronda
    Huggar, David
    Tian, Marc
    Mougalian, Sarah S.
    CANCER RESEARCH, 2020, 80 (04)
  • [24] Metastatic and triple-negative breast cancer: challenges and treatment options
    Sumayah Al-Mahmood
    Justin Sapiezynski
    Olga B. Garbuzenko
    Tamara Minko
    Drug Delivery and Translational Research, 2018, 8 : 1483 - 1507
  • [25] A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
    Zeichner, Simon B.
    Terawaki, Hiromi
    Gogineni, Keerthi
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2016, 10
  • [26] Emerging treatment strategies for metastatic triple-negative breast cancer
    Huppert, Laura A.
    Gumusay, Ozge
    Rugo, Hope S.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [27] Metastatic and triple-negative breast cancer: challenges and treatment options
    Al-Mahmood, Sumayah
    Sapiezynski, Justin
    Garbuzenko, Olga B.
    Minko, Tamara
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2018, 8 (05) : 1483 - 1507
  • [28] Innovations and Challenges in the Treatment of Metastatic Triple-Negative Breast Cancer
    McArthur, Heather L.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (05) : 290 - +
  • [29] Patterns of mutation enrichment in metastatic triple-negative breast cancer.
    Saravia, Cesar H.
    Flores, Claudio J.
    Schwarz, Luis Jesus
    Bravo, Leny
    Zavaleta, Jenny
    Araujo, Jhajaira M.
    Neciosup, Silvia P.
    Pinto, Joseph A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Economic Evaluation of Sacituzumab Govitecan for the Treatment of Metastatic Triple-Negative Breast Cancer in China and the US
    Chen, Jigang
    Han, Mingyang
    Liu, Aihua
    Shi, Bo
    FRONTIERS IN ONCOLOGY, 2021, 11
12345